[Exacerbation of psoriasis by treatment with alpha interferon].
Revenga Arranz
F
F
Castaño Suárez
E
E
Vanaclocha Sebastián
F
F
D000368:Aged; D003230:Conjunctival Neoplasms / Q000628:therapy*; D005260:Female; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects*; D011565:Psoriasis / Q000150:complications* / Q000473:pathology; D011994:Recombinant Proteins; D012514:Sarcoma, Kaposi / Q000628:therapy*; D012867:Skin / Q000473:pathology; D012878:Skin Neoplasms / Q000628:therapy*; D013997:Time Factors
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins
Exacerbación de la psoriasis por el tratamiento con interferón alfa.